Publikationen

• Diagnostics 2011 M&A surges, companion diagnostics accelerate, and early detection offers new prospects

  (English)

  PwC’s Diagnostics 2011 provides an overview of M&A deal activity during the past two years and the factors driving it, the development ...

  ---

• Insights for pharmaceutical and life science companies: Staying ahead of IFRS challenges

  (English)

  Financial reporting by US companies will undergo unprecedented change over the next several years. International Financial Reporting ...

  ---

• Key Pharmaceuticals & Life Sciences industry findings from 14th Annual Global CEO Survey Growth reimagined

  (English)

  The global economy is still recovering from the worst economic crisis in 75 years, as many countries grapple with the aftermath of the ...

  ---

• M&A Insights – Pharmaceutical Sector Analysis & opinions on global M&A activity from our network of local advisers 2006/2007

  (English)

  Welcome to the latest edition of M&A Insights, an annual review of deal activity and key trends within the pharmaceutical and ...

  ---

• Pay-For-Performance Arrangements: Guidance for Revenue Recognition under IFRS IFRS Revenue Recognition Guidance

  (English)

  Pay-For-Performance is a pricing concept under which the price paid for a given medicine is intended to reflect the economic benefits ...

  ---

• Pharma 2020 series Which path will you take?

  (English)

  ---

• The changing dynamics of pharma outsourcing in Asia Are you readjusting your sights?

  (English)

  The dynamics of pharma outsourcing and location decisions in Asia are changing. Cost reduction is being augmented and companies need ...

  ---

• US Healthcare Reform: Accounting Issues under IFRS

  (English)

  US Healthcare reform has raised some significant accounting issues for the pharmaceutical and life sciences sector, including the ...

  ---